Neuberger Berman Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13M | Sell |
144,308
-74,361
| -34% | -$6.82M | 0.01% | 757 |
|
|
2025
Q4 | $19.7M | Sell |
218,669
-161,626
| -43% | -$15.3M | 0.01% | 659 |
|
|
2025
Q3 | $37.5M | Sell |
380,295
-326,323
| -46% | -$32.3M | 0.03% | 525 |
|
|
2025
Q2 | $64.5M | Buy |
706,618
+97,189
| +16% | +$9.4M | 0.05% | 412 |
|
|
2025
Q1 | $69M | Buy |
609,429
+140,893
| +30% | +$15.1M | 0.06% | 371 |
|
|
2024
Q4 | $49.5M | Sell |
468,536
-77,971
| -14% | -$8.37M | 0.04% | 443 |
|
|
2024
Q3 | $59M | Sell |
546,507
-460,303
| -46% | -$50.2M | 0.05% | 415 |
|
|
2024
Q2 | $109M | Sell |
1,006,810
-640,178
| -39% | -$75.5M | 0.09% | 259 |
|
|
2024
Q1 | $217M | Sell |
1,646,988
-531,490
| -24% | -$66.4M | 0.18% | 144 |
|
|
2023
Q4 | $265M | Sell |
2,178,478
-265,524
| -11% | -$29.6M | 0.23% | 111 |
|
|
2023
Q3 | $274M | Sell |
2,444,002
-205,385
| -8% | -$26.1M | 0.25% | 101 |
|
|
2023
Q2 | $386M | Buy |
2,649,387
+24,855
| +0.9% | +$3.38M | 0.34% | 65 |
|
|
2023
Q1 | $339M | Buy |
2,624,532
+38,904
| +2% | +$4.88M | 0.31% | 74 |
|
|
2022
Q4 | $330M | Buy |
2,585,628
+219,712
| +9% | +$25.5M | 0.32% | 72 |
|
|
2022
Q3 | $247M | Sell |
2,365,916
-373,050
| -14% | -$40.9M | 0.26% | 94 |
|
|
2022
Q2 | $288M | Buy |
2,738,966
+518,917
| +23% | +$61.6M | 0.29% | 82 |
|
|
2022
Q1 | $284M | Buy |
2,220,049
+1,442,440
| +185% | +$174M | 0.24% | 109 |
|
|
2021
Q4 | $95.4M | Buy |
777,609
+63,642
| +9% | +$8.33M | 0.07% | 339 |
|
|
2021
Q3 | $101M | Buy |
713,967
+50,215
| +8% | +$7.39M | 0.09% | 304 |
|
|
2021
Q2 | $103M | Sell |
663,752
-32,799
| -5% | -$5.31M | 0.09% | 306 |
|
|
2021
Q1 | $108M | Buy |
696,551
+22,844
| +3% | +$3.54M | 0.1% | 282 |
|
|
2020
Q4 | $101M | Buy |
673,707
+26,819
| +4% | +$3.79M | 0.1% | 273 |
|
|
2020
Q3 | $85.5M | Sell |
646,888
-114,118
| -15% | -$14.9M | 0.1% | 267 |
|
|
2020
Q2 | $88.2M | Sell |
761,006
-367,157
| -33% | -$42.3M | 0.11% | 257 |
|
|
2020
Q1 | $111M | Sell |
1,128,163
-343,405
| -23% | -$45M | 0.17% | 166 |
|
|
2019
Q4 | $214M | Sell |
1,471,568
-51,569
| -3% | -$7.12M | 0.25% | 109 |
|
|
2019
Q3 | $203M | Sell |
1,523,137
-124,326
| -8% | -$16.1M | 0.25% | 109 |
|
|
2019
Q2 | $188M | Buy |
1,647,463
+363,083
| +28% | +$42.5M | 0.23% | 116 |
|
|
2019
Q1 | $159M | Buy |
1,284,380
+33,296
| +3% | +$3.78M | 0.2% | 143 |
|
|
2018
Q4 | $126M | Sell |
1,251,084
-271,562
| -18% | -$30.5M | 0.18% | 171 |
|
|
2018
Q3 | $194M | Sell |
1,522,646
-35,736
| -2% | -$4.25M | 0.22% | 133 |
|
|
2018
Q2 | $169M | Buy |
1,558,382
+142,062
| +10% | +$15.5M | 0.19% | 161 |
|
|
2018
Q1 | $150M | Buy |
1,416,320
+107,628
| +8% | +$12.5M | 0.17% | 185 |
|
|
2017
Q4 | $153M | Sell |
1,308,692
-79,997
| -6% | -$9.05M | 0.18% | 180 |
|
|
2017
Q3 | $158M | Sell |
1,388,689
-136,192
| -9% | -$15.7M | 0.2% | 161 |
|
|
2017
Q2 | $190M | Buy |
1,524,881
+215,147
| +16% | +$25.5M | 0.24% | 123 |
|
|
2017
Q1 | $155M | Buy |
1,309,734
+468,687
| +56% | +$53.1M | 0.2% | 160 |
|
|
2016
Q4 | $84.3M | Buy |
841,047
+434,368
| +107% | +$46.6M | 0.11% | 264 |
|
|
2016
Q3 | $51.3M | Sell |
406,679
-28,579
| -7% | -$3.53M | 0.07% | 373 |
|
|
2016
Q2 | $50.9M | Sell |
435,258
-63,678
| -13% | -$7.21M | 0.07% | 362 |
|
|
2016
Q1 | $51.7M | Sell |
498,936
-243,538
| -33% | -$23.6M | 0.07% | 353 |
|
|
2015
Q4 | $74M | Sell |
742,474
-492,378
| -40% | -$48.2M | 0.1% | 287 |
|
|
2015
Q3 | $113M | Sell |
1,234,852
-205,454
| -14% | -$20.6M | 0.15% | 209 |
|
|
2015
Q2 | $153M | Buy |
1,440,306
+105,089
| +8% | +$11.6M | 0.17% | 171 |
|
|
2015
Q1 | $152M | Buy |
1,335,217
+19,377
| +1% | +$2.21M | 0.16% | 178 |
|
|
2014
Q4 | $145M | Buy |
1,315,840
+266,293
| +25% | +$28.1M | 0.15% | 190 |
|
|
2014
Q3 | $102M | Buy |
1,049,547
+793,103
| +309% | +$78M | 0.11% | 269 |
|
|
2014
Q2 | $25.9M | Sell |
256,444
-18,791
| -7% | -$1.83M | 0.03% | 588 |
|
|
2014
Q1 | $25.3M | Sell |
275,235
-3,619
| -1% | -$334K | 0.03% | 588 |
|
|
2013
Q4 | $25.2M | Sell |
278,854
-99,481
| -26% | -$8.61M | 0.03% | 574 |
|
|
2013
Q3 | $30.2M | Sell |
378,335
-298,200
| -44% | -$23.5M | 0.03% | 519 |
|
|
2013
Q2 | $49.2M | Buy |
+676,535
| New | +$50.6M | 0.06% | 398 |
|
Other funds holding ZBH
VCM
VPM
Neuberger Berman Group's ZBH Position: Q1 2026 in Review
Neuberger Berman Group reduced its Zimmer Biomet (ZBH) stake by 34% in Q1 2026, selling an estimated $6.82M and leaving 144,308 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #757.
Neuberger Berman Group first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $386M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Neuberger Berman Group held 144,308 shares of Zimmer Biomet worth $13M as of Q1 2026.
- Neuberger Berman Group sold 74,361 Zimmer Biomet shares in Q1 2026, an estimated $6.82M.
- Zimmer Biomet made up 0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #757 holding.
- Neuberger Berman Group first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Neuberger Berman Group's Zimmer Biomet position peaked at $386M in Q2 2023.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.